Rigel Pharmaceuticals | Costo Del Venduto



Cost Of Sales Cambiamento Data
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.24B 484M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Celldex Therapeutics 45.26M 44.87M 2024-09
Daiichi Sankyo JPY 94.34B 34.04B 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Halozyme Therapeutics USD 48.4M 6.35M 2025-03
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
Ligand Pharmaceuticals USD 4.85M 2.01M 2025-03
MacroGenics USD 5.49M 3.62M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
Veracyte USD 34.96M 4.91M 2025-03



Rigel Pharmaceuticals Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.